**Background:** Cardiac arrest (CA) affects over 600,000 people annually in the United States, with overall survival to hospital discharge of 9% for out-of-hospital CA and 23% for in-hospital CA. Achieving return of spontaneous circulation (ROSC) is only the beginning of comprehensive, multisystem care, as most survivors remain unresponsive due to significant brain injury. Current guidelines provide few strong recommendations for post-CA care due to limited evidence, leading to wide variations in clinical practice. This scientific statement was developed by the American Heart Association and Neurocritical Care Society to address knowledge gaps and provide clinical guidance on topics where research and existing guidelines could not provide high certainty of evidence.
**Methods:** A multidisciplinary panel of experts was convened, including specialists from neurology, emergency medicine, cardiology, pulmonary, and intensive care, as well as nurses, pharmacists, and respiratory therapists. Topics were organized by organ system: neurological (brain oxygenation/perfusion/edema/ICP, seizures/ictal-interictal continuum, sedation/analgesia), cardiac, pulmonary, hematology, infectious disease, gastrointestinal, endocrine, fluids management, and general critical care. The panel used a modified Delphi approach to achieve consensus, with statements requiring >80% agreement among voting panelists. Literature searches were performed for each topic, and statements were refined through multiple voting cycles.
**Key Results:** The statement presents consensus statements across all organ systems. For neurological management, the panel recommends optimizing cerebral oxygen delivery by maintaining optimal cerebral perfusion pressure, arterial normocapnia, and adequate arterial oxygen content while avoiding hyperoxemia. In ICUs without advanced cerebral monitoring, target mean arterial pressure (MAP) >80 mm Hg is recommended. For seizures, continuous EEG monitoring for 72-120 hours is advised in patients who fail to recover consciousness, with valproic acid and levetiracetam as reasonable first-line agents. For sedation, short-acting agents (propofol, remifentanil, fentanyl) are preferred over midazolam and morphine. For cardiac management, echocardiography should be performed as soon as possible, and early coronary angiography may benefit patients without ST-segment elevation by potentially salvaging myocardium. For pulmonary management, lung-protective ventilation is standard, with FiO2 titrated to achieve SpO2 of 92-98% and Paco2 targeted at 35-45 mm Hg. For hematologic management, red blood cell transfusion is recommended when hemoglobin <7 g/dL, with higher thresholds (<9 g/dL) for acute coronary disease. Deep vein thrombosis prophylaxis should be initiated within 48 hours. For infectious disease, empirical antibiotics may be used in patients treated with hypothermic temperature control to reduce pneumonia incidence. For endocrine and fluids management, glucose targets of 81-180 mg/dL are recommended, and sodium bicarbonate should not be used routinely. The statement also emphasizes protocol-guided care, family support, and team-based care, recommending structured treatment protocols with input from multiple disciplines.
**Clinical Implications:** This scientific statement provides practical, consensus-based guidance for clinicians managing post-cardiac arrest patients in the ICU, addressing critical gaps where high-certainty evidence is lacking. The recommendations emphasize individualized, multimodal monitoring and treatment approaches, particularly for neurological and hemodynamic management. The statement highlights the importance of protocol-guided, multidisciplinary care and identifies numerous areas for future research, including optimal blood pressure targets, seizure management, mechanical circulatory support, and systems of care. By standardizing care and reducing practice variability, these consensus statements aim to improve outcomes for this complex patient population.